Registered entities
NEUROGENE INC.
Reg. No. 20241518368United States
Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 80 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Social engagement
Social engagement: 20K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Samsara BioCapital, EcoR1, Redmile Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Accelerator & incubator | 1 | 10% |
| Other / undisclosed | 6 | 60% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
15 Jan 2025 · QUALITY ASSURANCE SPECIALIST · null
Based on job postings tracked across public sources.
Recent activity
12 May 2026
Event
ASGCT2026
28 Apr 2026
Event
American Society of Gene & Cell Therapy Annual Meeting